维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="Hasselbalch HC"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The Role of reactive oxygen species in myelofibrosis and related neoplasms 显示文摘	Bjom ME Hasselbalch HC	2015	Mediators Inflamm2015，2015，64：	1
	2	B-cell depletion with rituximab-a targeted therapy for Graves' disease and autoimmune thyroiditis显示文摘	Hasselbalch HC	2003	Immunology Letters2003，88，：	1
	3	Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion显示文摘	El Fassi D Nielsen CH Hasselbalch HC	2006	Thyroid2006，16，：	1
	4	Hematological changes associatedwith human immunodeficiency virus(HIV-1)infection显示文摘	Moller T Hasselbalch HC	1993	Ugeskr Laeger1993，155，19：	1
	5	Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclemsis and second cancer? 显示文摘	Hasselbalch HC	2012	Blood2012，119，14：	1
	6	Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis 显示文摘	Hasselbalch HC Bjerrum OW Jensen BA	2003	Am J Hematol2003，74，4：	1
	7	Treatment- resistant severe, active Graves' ophthalraopathy successfully treated with B lymphocyte depletion显示文摘	Fassi DE Nielsen CH Hasselbalch HC Hegedtis L	2006	Thyroid2006，16，7：	1
	8	Treatment- resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion 显示文摘	El Fassi D Nielsen CH Hasselbalch HC	2006	Thyroid2006，16，：	1
	9	B-cell depletion with rituximab-a targeted therapy for Graves′ disease and autoimmune thyroiditis显示文摘	Hasselbalch HC	2003	Immunol Lett2003，88，：	1
	10	The JAK2 V617F mutation involves B-and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders显示文摘	Larsen TS Christensen JH Hasselbalch HC	2007	Br J Haematol2007，136，5：	1
	11	The JAK2 V617F mutation involves B- and T-lym- phocyte lineages in a subgroup of patients with Phila- delphia-chromosome negative chronic myeloprolifera- tire disorders显示文摘	Larsen TS Christensen JH Hasselbalch HC	2007	Br J Haematol2007，1361，：	1
	12	B-cell depletion with rituximab-a targeted therapy for Graves' disease and autoimmune thyroiditis显示文摘	Hasselbalch HC	2003	Immunol Lett2003，88，1：	1
	13	A new era for IFN - et in the treatment of Phila- delphia - negative chronic myeloproliferative neoplasms 显示文摘	Hasselbalch HC	2011	Expert Rev Hemato12011，4，6：	1
	14	Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan 显示文摘	Nielsen I Hasselbalch HC	2003	Am J Hematol2003，74，1：	1
	15	Acute leukemia and myelo- dysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan显示文摘	Nielsen I Hasselbalch HC	2003	Am J Hematol2003，74，：	1
	16	A phase DI randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia显示文摘	Birgens H Frederiksen H Hasselbalch HC	2013	Br J Haematol2013，163，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费